Wolf Greenfield Attorneys Review 2025 and Look Ahead to 2026
Practical IP Lessons From the Field Part Two: Navigating IP Risk in Oil & Gas - Energy Law Insights
USPTO Proposes New Rules to Limit Multiple Validity Challenges — Patents: Post-Grant Podcast
Unexpected Paths to IP Law with Jerry Hrycyszyn and Suresh Rav
It Only Took 13 Years: The Federal Circuit's First Derivation Proceeding Decision — Patents: Post-Grant Podcast
Understanding the Impact of IPR Estoppel and PTAB Discretionary Denials — Patents: Post-Grant Podcast
Navigating PTAB’s New Approach to IPR and PGR Discretionary Denial - Patents: Post-Grant Podcast
5 Key Takeaways | Building a Winning Evidentiary Record at the PTAB (and Surviving Appeal)
Director Review Under the USPTO's Final Rule – Patents: Post-Grant Podcast
Patent Considerations in View of the Nearshoring Trends to the Americas
4 Key Takeaways | Updates in Standard Essential Patent Licensing and Litigation
Behaving Badly: OpenSky v. VLSI and Sanctions at the PTAB — Patents: Post-Grant Podcast
Scott McKeown Discusses PTAB Trends and Growth of Wolf Greenfield’s Washington, DC Office
Wolf Greenfield Attorneys Preview What’s Ahead in 2024
USPTO Director Review — Patents: Post-Grant Podcast
5 Key Takeaways | PTAB Update: The Waning Impact of Fintiv on Discretionary Denials
3 Key Takeaways | Third party Prior Art Submissions at USPTO
Discretionary Denials at the PTAB: What to Expect? - Patents: Post-Grant Podcast
Secondary Considerations of Non-Obviousness - Patents: Post-Grant Podcast
JONES DAY TALKS®: Supreme Court Rules on Constitutionality of Administrative Patent Judges
Our Patent Case Summaries provide a weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial...more
The alacrity with which the Patent Trial and Appeal Board (PTAB) came to the same conclusion in its latest priority determination in favor of the Senior Party in interference No. 106,115 that it had almost eleven months ago...more
Fish & Richardson’s 2025 Post-Grant Report takes a deep dive into the cases, trends, and statistics that shaped Patent Trial and Appeal Board (PTAB) practice throughout the year and how they might affect practitioners going...more
On March 26, the Patent Trial and Appeal Board, without holding an oral hearing and despite a rather sharply worded opinion by the Federal Circuit vacating and remanding its earlier priority decision (see “Regents of the...more
The U.S. Court of Appeals for the Federal Circuit recently affirmed the Patent Trial and Appeal Board's (Board) rejection of a patent application directed to an "information exchange apparatus for determining an exchange...more
On March 16, the USPTO responded to a recent release of U.S. Chamber of Commerce 14th annual International IP Index report, which ranked the United States No. 1 on the index. Director Squires’ remarks, delivered on March 12...more
On March 26, 2026, the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB) reaffirmed its prior determination that the Broad Institute has priority over the University of California for the invention of a single-guide...more
In the April 1, 2026 issue of the Official Gazette, the U.S. Patent and Trademark Office published a new process permitting patent owners to file an early, limited response to a request for ex parte reexamination....more
Some inventors find their inventive spark through science fiction. Tasers, for example, were inspired by (and named after) the 1911 novel Tom Swift and His Electric Rifle. Likewise, Motorola’s early cellphones were heavily...more
Over the past year, the USPTO has made a series of significant changes to inter partes review and post‑grant review practice that have reduced institution rates, expanded discretionary denials, and made outcomes harder to...more
In Netflix, Inc. v. DivX, LLC, the Federal Circuit reversed the Patent Trial and Appeal Board’s claim construction in an inter partes review and vacated its non‑obviousness decision....more
On April 1, 2026, USPTO Director John Squires issued an Official Gazette Notice establishing a new pre-order procedure effective for reexamination requests filed on or after April 5, 2026....more
On March 30, 2026, United States District Judge Paul G. Gardephe (S.D.N.Y) denied Defendant New Jersey Transit Corporation’s (“NJ Transit”) motion for summary judgment on all of Plaintiff Bytemark, Inc.’s (“Bytemark”) claims....more
Have you, your paralegal, your client, your expert, etc. used public generative artificial intelligence (“AI”) to perform research while preparing for a USPTO invalidity proceeding as a challenger or patent owner?...more
The number of patents for quantum computing inventions is rapidly increasing as the industry increasingly moves towards greater commercialization. Patenting quantum computing inventions raises several recurring legal issues,...more
The Director of the U.S. Patent Office, John Squires, entered an order on Thursday, March 6, 2026, stating that he will convene a sua sponte rehearing regarding the Board’s 2025 decision regarding obviousness-type double...more
On February 13, 2026, the United States Court of Appeals for the Federal Circuit issued its precedential decision in Apple Inc. v. Squires, Case No. 2024-1864 (Fed. Cir. Feb. 13, 2026), affirming the Northern District of...more
At a March 25, 2026, oversight hearing, the House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet questioned U.S. Patent and Trademark Office (USPTO) Director John A. Squires...more
On March 20, 2026, Accord, Intas, and Bio-Thera Solutions filed four petitions for inter partes review (“IPR”) challenging Janssen patents related to Simponi® (golimumab). ...more
On March 20, 2026, Accord BioPharma, Inc. (“Accord”), Intas Pharmaceuticals Ltd. (“Intas”), and Bio-Thera Solutions, Ltd. (“Bio-Thera,” collectively “Petitioners”) filed four Inter Partes Review petitions (“IPRs”) challenging...more
Despite a pointed decision by the Federal Circuit vacating and remanding the matter to the Patent Trial and Appeal Board, yesterday the Board once again granted priority for CRISPR technology to the Broad Institute. A more...more
USPTO Director John Squires issued a decision on November 5, 2025, vacating a prior institution decision and denying institution in Tesla, Inc. v. Intellectual Ventures II LLC, IPR2025-00340, Paper 18. ...more
Under the Trump administration, the USPTO has significantly overhauled its approach in evaluating whether to discretionarily deny inter partes review (IPR) and post-grant review (PGR) petitions. On March 26, 2025, the Acting...more
On March 11 and March 13, 2026, the U.S. Patent and Trademark Office (USPTO) and the White House released a memorandum and executive order, respectively, that reemphasize this administration’s focus on promoting domestic...more